These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 14620515)
1. In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier. Cisternino S; Rousselle C; Debray M; Scherrmann JM Pharm Res; 2003 Oct; 20(10):1607-11. PubMed ID: 14620515 [TBL] [Abstract][Full Text] [Related]
2. In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier. Cisternino S; Rousselle C; Debray M; Scherrmann JM Pharm Res; 2004 Aug; 21(8):1382-9. PubMed ID: 15359572 [TBL] [Abstract][Full Text] [Related]
3. Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice. Cisternino S; Rousselle C; Dagenais C; Scherrmann JM Pharm Res; 2001 Feb; 18(2):183-90. PubMed ID: 11405289 [TBL] [Abstract][Full Text] [Related]
4. Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine. Drion N; Lemaire M; Lefauconnier JM; Scherrmann JM J Neurochem; 1996 Oct; 67(4):1688-93. PubMed ID: 8858954 [TBL] [Abstract][Full Text] [Related]
5. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373 [TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells. Declèves X; Chappey O; Boval B; Niel E; Scherrmann JM Pharm Res; 1998 May; 15(5):712-8. PubMed ID: 9619779 [TBL] [Abstract][Full Text] [Related]
7. Flavonoid permeability across an in situ model of the blood-brain barrier. Youdim KA; Qaiser MZ; Begley DJ; Rice-Evans CA; Abbott NJ Free Radic Biol Med; 2004 Mar; 36(5):592-604. PubMed ID: 14980703 [TBL] [Abstract][Full Text] [Related]
8. Role of P-glycoprotein in colchicine and vinblastine cellular kinetics in an immortalized rat brain microvessel endothelial cell line. El Hafny B; Cano N; Piciotti M; Regina A; Scherrmann JM; Roux F Biochem Pharmacol; 1997 Jun; 53(11):1735-42. PubMed ID: 9264327 [TBL] [Abstract][Full Text] [Related]
9. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier. Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045 [TBL] [Abstract][Full Text] [Related]
10. Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells. Cisternino S; Rousselle C; Lorico A; Rappa G; Scherrmann JM Pharm Res; 2003 Jun; 20(6):904-9. PubMed ID: 12817896 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein. Kusunoki N; Takara K; Tanigawara Y; Yamauchi A; Ueda K; Komada F; Ku Y; Kuroda Y; Saitoh Y; Okumura K Jpn J Cancer Res; 1998 Nov; 89(11):1220-8. PubMed ID: 9914792 [TBL] [Abstract][Full Text] [Related]
12. Modulation of P-glycoprotein activity by glial factors and retinoic acid in an immortalized rat brain microvessel endothelial cell line. El Hafny B; Chappey O; Piciotti M; Debray M; Boval B; Roux F Neurosci Lett; 1997 Oct; 236(2):107-11. PubMed ID: 9404823 [TBL] [Abstract][Full Text] [Related]
13. Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier. Dirson G; Fernandez C; Hindlet P; Roux F; German-Fattal M; Gimenez F; Farinotti R Pharm Res; 2006 Jul; 23(7):1525-32. PubMed ID: 16779703 [TBL] [Abstract][Full Text] [Related]
14. Involvement of P-glycoprotein in blood-brain barrier transport of pentazocine in rats using brain uptake index method. Moriki Y; Suzuki T; Fukami T; Hanano M; Tomono K; Watanabe J Biol Pharm Bull; 2004 Jun; 27(6):932-5. PubMed ID: 15187451 [TBL] [Abstract][Full Text] [Related]
15. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier. Bihorel S; Camenisch G; Lemaire M; Scherrmann JM J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988 [TBL] [Abstract][Full Text] [Related]
16. Increase in P-glycoprotein levels in the blood-brain barrier of partial portal vein ligation /chronic hyperammonemia rats is medicated by ammonia/reactive oxygen species/ERK1/2 activation: In vitro and in vivo studies. Zhou Y; Zhou J; Li P; Xie Q; Sun B; Li Y; Chen Y; Zhao K; Yang T; Zhu L; Xu J; Liu X; Liu L Eur J Pharmacol; 2019 Mar; 846():119-127. PubMed ID: 30639310 [TBL] [Abstract][Full Text] [Related]
17. Interaction of drugs with P-glycoprotein in brain capillaries. Jetté L; Murphy GF; Leclerc JM; Beliveau R Biochem Pharmacol; 1995 Nov; 50(10):1701-9. PubMed ID: 7503774 [TBL] [Abstract][Full Text] [Related]
19. The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells. Svane N; Pedersen ABV; Rodenberg A; Ozgür B; Saaby L; Bundgaard C; Kristensen M; Tfelt-Hansen P; Brodin B Fluids Barriers CNS; 2024 May; 21(1):39. PubMed ID: 38711118 [TBL] [Abstract][Full Text] [Related]
20. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. Bourasset F; Cisternino S; Temsamani J; Scherrmann JM J Neurochem; 2003 Sep; 86(6):1564-7. PubMed ID: 12950465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]